Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / ADR
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
24,920
-
Shares change
-
-5,057
-
Total reported value, excl. options
-
$1,408,997
-
Value change
-
-$351,199
-
Number of buys
-
3
-
Number of sells
-
5
-
Price
-
$56.54
Institutional Holders of NOVOZYMES AS/FI - ADR (NVZMY) as of Q4 2024
As of 31 Dec 2024 NOVOZYMES AS/FI - ADR (NVZMY) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,920 shares of stock of the company.
Largest 10 holders included RHUMBLINE ADVISERS, Sterling Capital Management LLC, S&CO INC, PNC Financial Services Group, Inc., GAMMA Investing LLC, MAR VISTA INVESTMENT PARTNERS LLC, Brooklyn Investment Group, Copeland Capital Management, LLC, Eagle Bay Advisors LLC, and Boston Common Asset Management, LLC.
This table shows 10 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.